Evidence map›Paper›PMID 36997700›Full record

ArticleNature chemistry2023

OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissues.

Lei G Wang, Antonio R Montaño, Jason R Combs, Nathan P McMahon, Allison Solanki, Michelle M Gomes, Kai Tao, William H Bisson, Dani A Szafran, Kimberley S Samkoe and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Nature chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Regulation of RNA-binding proteins by small biomolecules.Nature reviews. Molecular cell biology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Overcoming aggregation-induced quenching in DNA-assembled rhodamine dimers.Physical chemistry chemical physics : PCCP · 2025
    Article
  7. Article
  8. Article
  9. A Small-Molecule Drug for the Self-Checking of Mitophagy.Angewandte Chemie (International ed. in English) · 2025
    Article
  10. High-affinity agonism at the P2XNature communications · 2024
    Article
  11. Article
  12. Theranostics · 2024
    Article
  13. Research square · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Lei G WangBiomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-0664-2704
Antonio R MontañoBiomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-3667-2338
Jason R CombsBiomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA.
Nathan P McMahonBiomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA.
Allison SolankiBiomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA.
Michelle M GomesCancer Early Detection Advanced Research Center (CEDAR), Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-4809-2664
Kai TaoCancer Early Detection Advanced Research Center (CEDAR), Oregon Health & Science University, Portland, OR, USA.
William H BissonKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Dani A SzafranBiomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0001-6408-9233
Kimberley S SamkoeThayer School of Engineering, Dartmouth College, Hanover, NH, USA.ORCID http://orcid.org/0000-0002-8234-2308
Kenneth M TichauerDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
Summer L GibbsBiomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA. gibbss@ohsu.edu.ORCID http://orcid.org/0000-0001-8077-1582

Funding

A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase InhibitorsR21CA257942 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GIBBS, SUMMER LYNNE · 2022 to 2024
$622k
NCI NIH HHS R21 CA257942
6 · The paper itself

Abstract

Non-destructive fluorophore diffusion across cell membranes to provide an unbiased fluorescence intensity readout is critical for quantitative imaging applications in live cells and tissues. Commercially available small-molecule fluorophores have been engineered for biological compatibility, imparting high water solubility by modifying rhodamine and cyanine dye scaffolds with multiple sulfonate groups. The resulting net negative charge, however, often renders these fluorophores cell-membrane-impermeant. Here we report the design and development of our biologically compatible, water-soluble and cell-membrane-permeable fluorophores, termed OregonFluor (ORFluor). By adapting previously established ratiometric imaging methodology using bio-affinity agents, it is now possible to use small-molecule ORFluor-labelled therapeutic inhibitors to quantitatively visualize their intracellular distribution and protein target-specific binding, providing a chemical toolkit for quantifying drug target availability in live cells and tissues.

Indexed as

Fluorescent DyesWaterRhodaminesFluorescent DyesRhodaminesWater

Identifiers

PMID36997700
PMCPMC10965356

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.